Rotavirus-like particle production in plants

Patent metadata

Field	Value
Publication number	US-2015216961-A1
Application number	US-201314398650-A
Country	US
Kind code	A1
Filing date	May 10, 2013
Priority date	May 11, 2012
Publication date	Aug 6, 2015
Grant date	—

Abstract

A method of producing a virus-like particle (VLP) in a plant is provided. The method comprises introducing a first nucleic acid into the plant, or portion of the plant. The first nucleic acid comprising a first regulatory region active in the plant operatively linked to a nucleotide sequence encoding one or more rotavirus structural protein for example but not limited to rotavirus protein VP2. The nucleotide sequence may further comprise one or more than one amplification element and/or a compartment targeting sequence. A second nucleic acid might be introduced into the plant, or portion of the plant. The second nucleic acid comprises a second regulatory region active in the plant and operatively linked to a nucleotide sequence encoding one or more rotavirus structural protein, for example but not limited to rotavirus protein VP6. Optionally, a third nucleic acid and/or fourth nucleic acid might be introduced into the plant, or portion of the plant. The third nucleic acid comprises a third regulatory region active in the plant and operatively linked to a nucleotide sequence encoding one or more rotavirus structural protein, for example but not limited to rotavirus protein VP4. The fourth nucleic acid comprises a fourth regulatory region active in the plant and operatively linked to a nucleotide sequence encoding one or more rotavirus structural protein, for example but not limited to rotavirus protein VP7. The plant or portion of the plant is incubated under conditions that permit the expression of the nucleic acids, thereby producing the VLP.

First claim

What is claimed is:

1 . A method of producing a rotavirus like particle (RLP) in a plant, portion of a plant or plant cell, comprising:
a) introducing a first nucleic acid comprising a first regulatory region active in the plant operatively linked to a first nucleotide sequence encoding a first rotavirus structural protein, a second nucleic acid comprising a second regulatory region active in the plant operatively linked to a second nucleotide sequence encoding a second rotavirus structural protein and a third nucleic acid comprising a third regulatory region active in the plant operatively linked to a third nucleotide sequence encoding a third rotavirus structural protein into the plant, portion of a plant or plant cell, b) incubating the plant, portion of a plant or plant cell under conditions that permit the transient expression of the first, second and third nucleic acid, thereby producing the RLP.

2 . The method of claim 1 , wherein a fourth nucleic acid comprising a fourth regulatory region active in the plant and operatively linked to a fourth nucleotide sequence encoding a fourth rotavirus structural protein is introduced into the plant, portion of a plant or plant cell in step a), and is expressed when incubating the plant, portion of a plant or plant cell in step b).

3 . The method of claim 1 , wherein the first rotavirus structural protein is VP2, the second rotavirus structural protein is VP6 and the third rotavirus structural protein is VP4.

4 . The method of claim 1 , wherein the first rotavirus structural protein is VP2, the second rotavirus structural protein is VP6 and the third rotavirus structural protein is VP7.

5 . The method of claim 2 , wherein the first rotavirus structural protein is VP2, the second rotavirus structural protein is VP6, the third rotavirus structural protein is VP4 and the fourth rotavirus structural protein is VP7.

6 . The method of claim 1 or 2 , wherein an additional nucleic acid is expressed in the plant, portion of a plant or plant cell, and wherein the additional nucleic acid comprises a regulatory region active in the plant operatively linked to a nucleotide sequence encoding a suppressor of silencing.

7 . The method of claim 1 or 2 , wherein the codon usage of the nucleotide sequence is adjusted to preferred human codon usage, increased GC content or a combination thereof.

8 . The method of claim 1 or 2 , wherein the rotavirus structural protein comprises a truncated, native or a non-native signal peptide.

9 . The method of claim 8 , wherein the non-native signal peptide is a protein disulfide isomerase signal (PDI) peptide.

10 . The method of claim 1 , wherein the first, second or third nucleotide sequence or a combination thereof is operatively linked to a Cowpea Mosaic Virus (CPMV) regulatory region.

11 . The method of claim 2 , wherein the first, second, third or fourth nucleotide sequence or a combination thereof is operatively linked to a Cowpea Mosaic Virus (CPMV) regulatory region.

12 . The method of claim 1 or 2 , further comprising the steps of:
c) harvesting the plant, portion of a plant or plant cell, and
d) purifying the RLPs from the plant, portion of a plant or plant cell, wherein the RLPs range in size from 70-100 nm.

13 . The method of claim 12 , wherein the RLP is purified in the presence of calcium.

14 . A RLP produced by the method of claim 1 or 2 , wherein the RLP comprising at least aVP4 rotavirus structural protein.

15 . A RLP produced by the method of claim 3 , wherein the RLP is a double layered RLP.

16 . A RLP produced by the method of claim 4 or 5 , wherein the RLP is a triple layered RLP.

17 . The method of claim 1 or 2 , wherein the rotavirus structural protein is selected from rotavirus strain G9 P[6], rotavirus A WA strain, rotavirus A vaccine USA/Rotarix-A41CB052A/1988/G1P1A[8] strain and rotavirus SA11 strain.

18 . The method of any one of claims 3 , 4 and 5 , wherein the nucleotide sequence encoding VP2 comprises from 80% to 100% identity with a nucleotide sequence as defined by SEQ ID NO:13, SEQ ID NO:14, or SEQ ID NO: 45.

19 . The method of any one of claims 3 , 4 and 5 , wherein the nucleotide sequence encoding VP6 comprises from 80% to 100% identity with a nucleotide sequence as defined by SEQ ID NO:17, SEQ ID NO:18 or SEQ ID NO:46.

20 . The method of any one of claims 4 and 5 , wherein the nucleotide sequence encoding VP7 comprises from 80% to 100% identity with a nucleotide sequence as defined by SEQ ID NO: 19, 20, 48, 49, 52, 53, 54 or 57.

21 . The method of any one of claims 3 , and 5 , wherein the nucleotide sequence encoding VP4 comprises from 80% to 100% identity with a nucleotide sequence as defined by SEQ ID NO: 15, 16, 47, 50, or 51.

22 . The method of any one of claims 3 , 4 and 5 , wherein VP2 is encoded by an amino acid sequence comprising from 80% to 100% identity with the amino acid sequence defined by SEQ ID NO:1 or SEQ ID NO: 25.

23 . The method of any one of claims 3 , 4 and 5 , wherein VP6 is encoded by an amino acid sequence comprising from 80% to 100% identity with the amino acid sequence defined by SEQ ID NO:3 or SEQ ID NO: 31.

24 . The method any one of claims 4 and 5 , wherein VP7 is encoded by an amino acid sequence comprising from 80% to 100% identity with the amino acid sequence defined by SEQ ID NO: 4, 39, 43 or 59.

25 . The method of any one of claims 3 and 5 , wherein VP4 is encoded by an amino acid sequence comprising from 80% to 100% identity with the amino acid sequence defined by SEQ ID NO: 2 or SEQ ID NO: 36.

26 . The method of claim 1 , wherein the first, second or third nucleic acid sequence or a combination thereof comprises a regulatory region active in the plant operatively linked to one or more than one comovirus enhancer, to one or more than one amplification element and to a nucleotide sequence encoding a rotavirus structural protein, and wherein a fourth nucleic acid encoding a replicase is introduced into the plant, portion of a plant or plant cell.

27 . The method of claim 2 , wherein the first, second, third or fourth nucleic acid sequence or a combination thereof comprises a regulatory region active in the plant operatively linked to one or more than one comovirus enhancer, to one or more than one amplification element and to a nucleotide sequence encoding a rotavirus structural protein, and wherein a fifth nucleic acid encoding a replicase is introduced into the plant, portion of a plant or plant cell.

28 . The method of claim 1 , wherein at the first, second or third nucleotide sequence or a combination thereof is further operatively linked to a compartment targeting sequence.

29 . The method of claim 2 , wherein the first, second, third or fourth nucleotide sequence or a combination thereof is further operatively linked to a compartment targeting sequence.

30 . A method of producing a rotavirus like particle (RLP) in a plant, portion of a plant or plant cell, comprising:
a) introducing a nucleic acid comprising a regulatory region active in the plant operatively linked to a first nucleotide sequence encoding one or more rotavirus structural protein, into the plant, portion of a plant or plant cell, b) incubating the plant, portion of a plant or plant cell under conditions that permit the transient e

Assignees

• Medicago Inc
• Mitsubishi Tanabe Pharma Corp

Inventors

• D Aoust Marc-Andre
• Landry Nathalie
• Lavoie Pierre-Olivier
• Arai Masaaki
• Asahara Naomi
• Mutepfa David Levi Rutendo
• Hitzeroth Inga Isabel
• Rybicki Edward Peter

Classifications

• A61P31/14

  for RNA viruses · CPC title

• A61P37/04

  Immunostimulants · CPC title

• C12N2720/12351

  Methods of production or purification of viral material · CPC title

• C12N15/8203

  Virus mediated transformation · CPC title

• C12N15/8218

  Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS] · CPC title